nach oben

18.04.2024 | case report

Masqueraded sebaceous gland carcinoma of the lower eyelid in a young pregnant patient

verfasst von: Karla Randelovic, MD, FEBO, Ivanka Petric Vickovic, MD, PhD, Valentina Lacmanovic Loncar, MD, PhD, Leo Pazanin, MD, PhD, Anita Pusic Sesar, MD, PhD, Renata Ivekovic, MD, PhD, Zoran Vatavuk, MD, PhD

Erschienen in: Wiener klinische Wochenschrift

Einloggen, um Zugang zu erhalten

Summary

The purpose of this case report is to present misdiagnosed sebaceous gland carcinoma of the lower eyelid with rapid growth in a young woman during pregnancy. Eyelid sebaceous gland carcinoma is a relatively rare tumor and a disease primarily of older patients. It occurs more commonly in oriental populations and with a predilection for the upper eyelid. Early diagnosis and appropriate treatment may help improve disease control and patient survival.

Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50:103–22.CrossRefPubMed

Muqit MM, Foot B, Walters SJ, Mudhar H, Roberts F, Rennie IG. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophthalmol. 2013;97:47–51.CrossRefPubMed

Owen JL, et al. Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA et al. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol. 2019;20:e699–e714.CrossRefPubMed

Takahashi Y, Takahashi E, Nakakura S, Kitaguchi Y, Mupas-Uy J, Kakizaki H. Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control. Am J Ophthalmol. 2016;171:67–74.CrossRefPubMed

Zhou C, Wu F, Chai P, Shi Y, Ye J, Shi X, et al. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients. J Am Acad Dermatol. 2019;80:1608–17.CrossRefPubMed

While B, Salvi S, Currie Z, Mudhar HS, Tan JH. Excision and delayed reconstruction with paraffin section histopathological analysis for periocular sebaceous carcinoma. Ophthalmic Plast Reconstr Surg. 2014;30:105–9.CrossRefPubMed

Kibbi N, Worley B, Owen JL, Kelm RC, Bichakjian CK, Chandra S, et al. Sebaceous carcinoma: controversies and their evidence for clinical practice. Arch Dermatol Res. 2020;312:25–23.CrossRefPubMed

Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, et al. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol. 2019;103:980–4.CrossRefPubMed

Cho KJ, Khang KS, Koh JS, Chung JH, Lee SS. Sebaceous carcinoma of the eyelids: frequent expression of c‑erbB‑2 oncoprotein. J Korean Med Sci. 2000;15:545–50.CrossRefPubMedPubMedCentral

10.

Na HY, Choe JY, Shin SA, Choung HK, Oh S, Chung JH, et al. Proposal of a Provisional Classification of Sebaceous Carcinoma Based on Hormone Receptor Expression and HER2 Status. Am J Surg Pathol. 2016;40:1622–30.CrossRefPubMed

Titel: Masqueraded sebaceous gland carcinoma of the lower eyelid in a young pregnant patient
verfasst von: Karla Randelovic, MD, FEBO
Ivanka Petric Vickovic, MD, PhD
Valentina Lacmanovic Loncar, MD, PhD
Leo Pazanin, MD, PhD
Anita Pusic Sesar, MD, PhD
Renata Ivekovic, MD, PhD
Zoran Vatavuk, MD, PhD
Publikationsdatum: 18.04.2024
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-024-02349-x

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten